tm
Seeing Is Believing
tm
Seeing Is Believing
FATE is currently covered by 13 analysts with an average potential upside of $10.76 (37.14%) from yesterday's end of day stock price of $2.37. Fate Therapeutics activity chart has currently 122 price targets and 123 ratings on display.
Analysts average stock forecasts to be materialized ratio is 64.94% with an average time for these price targets to be met of 97 days.
Highest price target for FATE is $60, Lowest price target is $2, average price target is $31.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 20-Nov-2023. First documented stock forecast 06-May-2015.
Currently, out of the existing stock ratings of FATE - 21 which are a Buy (60%), 13 which are a Hold (37.14%), 1 which are a Sell (2.86%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$5.63 (237.55%)
16 days ago
6/7 (85.71%)
$6.2 (57.81%)
109
Hold
3
$0.63 (26.58%)
8
23 days ago
0/6 (0%)
$7.97 (43.01%)
Hold
6
$3.63 (153.16%)
5.4
27 days ago
0/4 (0%)
$7.53 (95.25%)
Hold
3
$0.63 (26.58%)
74
27 days ago
3/5 (60%)
$6.04 (23.93%)
61
Hold
3 months 20 days ago
2/3 (66.67%)
$13.69 (35.00%)
10
What is FATE (Fate Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FATE (Fate Therapeutics)?
Which analyst is the currently most bullish on FATE (Fate Therapeutics)?
Which analyst is the currently most reserved on FATE (Fate Therapeutics)?
